Literature DB >> 22588327

Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia.

Takakazu Higuchi, Takeshi Okamoto, Toshiyuki Kou, Tadashi Takeuchi, Ryosuke Koyamada, Sadamu Okada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22588327     DOI： 10.1007/s00277-012-1485-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.

Authors:  Hina Ogawa; Masayoshi Souri; Kazunori Kanouchi; Tsukasa Osaki; Rie Ohkubo; Tomoko Kawanishi; Sachiko Wakai; Keita Morikane; Akitada Ichinose
Journal:  Int J Hematol       Date:  2018-11-16       Impact factor: 2.490

2.  Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report.

Authors:  Naif I Aljohani; John H Matthews
Journal:  Int Med Case Rep J       Date:  2014-02-24

3.  Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.

Authors:  Xiangyu Wang; Xuemei Qin; Yuan Yu; Ran Wang; Xinguang Liu; Min Ji; Minran Zhou; Chunyan Chen
Journal:  Blood Coagul Fibrinolysis       Date:  2017-06       Impact factor: 1.276

4.  Acquired Factor V Inhibitor Complicated with Immune Thrombocytopenia.

Authors:  Fuka Mima; Ryota Minami; Mizuki Asako; Hitomi Matsunaga; Yuri Fujita; Yoshimi Takimoto; Sonoko Senda; Wataru Nakahara; Mako Ikeda; Shuji Ueda
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.